These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 1969616
1. Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B. Bruskin A, Jackson J, Bishop JM, McCarley DJ, Schatzman RC. Oncogene; 1990 Jan; 5(1):15-24. PubMed ID: 1969616 [Abstract] [Full Text] [Related]
2. Increase in ribosomal protein S6 phosphorylation is due to v-erbB-transforming activity and not to v-erbA mitogenic activity in avian erythroblastosis virus-infected chicken embryo fibroblasts. Diaz JJ, Gandrillon O, Hentzen D, Leguellec D, Samarut J, Madjar JJ. Oncogene Res; 1989 Jan; 4(3):163-75. PubMed ID: 2567979 [Abstract] [Full Text] [Related]
3. Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B. Miller M, Kennewell A, Takayama Y, Bruskin A, Bishop JM, Johnson G, Symonds G. Oncogene; 1990 Aug; 5(8):1125-31. PubMed ID: 2168027 [Abstract] [Full Text] [Related]
5. Mutational analysis of the role of the carboxy-terminal region of the v-erbB protein in erythroid cell transformation. Lee EB, Beug H, Hayman MJ. Oncogene; 1993 May; 8(5):1317-27. PubMed ID: 8097581 [Abstract] [Full Text] [Related]
6. Transformation by v-Myb. Lipsick JS, Wang DM. Oncogene; 1999 May 13; 18(19):3047-55. PubMed ID: 10378700 [Abstract] [Full Text] [Related]
8. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Ahmed NN, Franke TF, Bellacosa A, Datta K, Gonzalez-Portal ME, Taguchi T, Testa JR, Tsichlis PN. Oncogene; 1993 Jul 13; 8(7):1957-63. PubMed ID: 8510938 [Abstract] [Full Text] [Related]
9. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors. Schroeder C, Raynoschek C, Fuhrmann U, Damm K, Vennström B, Beug H. Oncogene; 1990 Oct 13; 5(10):1445-53. PubMed ID: 1979159 [Abstract] [Full Text] [Related]
10. Retroviral capture of c-erbB proto-oncogene sequences: rapid evolution of distinct viral genomes carrying mutant v-erbB genes with different transforming capacities. Vennström B, Raynoscheck C, Jansson L, Doederlein G, Lhotak V, Johnsson A, Beug H. Oncogene; 1994 May 13; 9(5):1307-20. PubMed ID: 8152791 [Abstract] [Full Text] [Related]
17. v-erbA cooperates with bFGF in neuroretina cell transformation. Garrido C, Li RP, Samarut J, Gospodarowicz D, Saule S. Virology; 1993 Feb 17; 192(2):578-86. PubMed ID: 7678474 [Abstract] [Full Text] [Related]
18. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice. Kurie JM, Morse HC, Principato MA, Wax JS, Troppmair J, Rapp UR, Potter M, Mushinski JF. Oncogene; 1990 Apr 17; 5(4):577-82. PubMed ID: 2183159 [Abstract] [Full Text] [Related]
19. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf. Topol LZ, Marx M, Calothy G, Blair DG. Cell Growth Differ; 1995 Jan 17; 6(1):27-38. PubMed ID: 7718484 [Abstract] [Full Text] [Related]
20. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro. Cleveland JL, Jansen HW, Bister K, Fredrickson TN, Morse HC, Ihle JN, Rapp UR. J Cell Biochem; 1986 Jan 17; 30(3):195-218. PubMed ID: 3084503 [Abstract] [Full Text] [Related] Page: [Next] [New Search]